Zacks Investment Research lowered shares of Transcat (NASDAQ:TRNS) from a hold rating to a sell rating in a report published on Wednesday, December 20th.
According to Zacks, “Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace. “
A number of other equities research analysts also recently commented on TRNS. Dougherty & Co initiated coverage on Transcat in a report on Wednesday, August 23rd. They issued a buy rating and a $20.00 price target on the stock. Singular Research initiated coverage on Transcat in a report on Wednesday, November 15th. They issued a buy rating and a $15.30 price target on the stock.
Transcat (NASDAQ TRNS) traded down $0.15 during midday trading on Wednesday, hitting $13.85. The stock had a trading volume of 2,829 shares, compared to its average volume of 19,642. The company has a market capitalization of $100.38, a price-to-earnings ratio of 23.03, a price-to-earnings-growth ratio of 3.38 and a beta of 0.45. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.53 and a current ratio of 2.24. Transcat has a 1 year low of $10.50 and a 1 year high of $15.15.
A number of hedge funds have recently modified their holdings of TRNS. Northern Trust Corp raised its stake in shares of Transcat by 9.5% during the 2nd quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock valued at $220,000 after buying an additional 1,570 shares during the last quarter. QCI Asset Management Inc. NY raised its stake in shares of Transcat by 10.0% during the 2nd quarter. QCI Asset Management Inc. NY now owns 24,587 shares of the scientific and technical instruments company’s stock valued at $299,000 after buying an additional 2,226 shares during the last quarter. Quantum Capital Management purchased a new position in shares of Transcat during the 3rd quarter valued at about $696,000. Vanguard Group Inc. raised its stake in shares of Transcat by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock valued at $1,623,000 after buying an additional 4,450 shares during the last quarter. Finally, Neuberger Berman Group LLC raised its stake in shares of Transcat by 3.1% during the 2nd quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock valued at $2,005,000 after buying an additional 4,900 shares during the last quarter. Institutional investors own 56.69% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Transcat (NASDAQ:TRNS) Cut to “Sell” at Zacks Investment Research” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/01/13/transcat-trns-rating-lowered-to-sell-at-zacks-investment-research.html.
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
Get a free copy of the Zacks research report on Transcat (TRNS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.